Declared Dividend • 5h
Fourth quarter dividend of CA$0.09 announced Shareholders will receive a dividend of CA$0.09. Ex-date: 10th July 2026 Payment date: 4th August 2026 Dividend yield will be 1.2%, which is higher than the industry average of 0.2%. Sustainability & Growth Dividend is not covered by earnings (128% earnings payout ratio). However, it is well covered by cash flows (43% cash payout ratio). The dividend has increased by an average of 14% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. The company's earnings per share (EPS) would need to grow by 42% to bring the payout ratio under control. EPS is expected to grow by 140% over the next 2 years, which is sufficient to bring the dividend into a sustainable range. New Risk • Jul 02
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 38% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 6.4% per year over the past 5 years. Minor Risks Large one-off items impacting financial results. Significant insider selling over the past 3 months (CA$224k sold). Ankündigung • Jul 01
Tecsys Inc. Declares Quarterly Dividend, Payable August 4, 2026 On June 29, 2026, Tecsys Inc. declared a quarterly dividend of CAD 0.09 per share to be paid on August 4, 2026, to shareholders of record on July 10, 2026. Ankündigung • Jun 30
Tecsys Inc. Provides Earnings Guidance for Fiscal Year 2027 Tecsys Inc. provided earnings guidance for fiscal year 2027. For the year, the company expects total revenue growth to be between 2% to 4%. Ankündigung • Jun 24
Tecsys Inc., Annual General Meeting, Sep 10, 2026 Tecsys Inc., Annual General Meeting, Sep 10, 2026. Recent Insider Transactions • Jun 16
Chairman of the Board recently sold CA$62k worth of stock On the 12th of June, David Brereton sold around 2k shares on-market at roughly CA$36.47 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger sale worth CA$86k. David has been a net seller over the last 12 months, reducing personal holdings by CA$766k. Ankündigung • Jun 16
Tecsys Inc. to Report Q4, 2026 Results on Jun 29, 2026 Tecsys Inc. announced that they will report Q4, 2026 results After-Market on Jun 29, 2026 Ankündigung • Jun 15
Tecsys Achieves FedRAMP Agency Auth In Process Designation With HHS Sponsorship Tecsys Inc. has been officially designated as 'Agency Auth In Process' on the FedRAMP Marketplace, following sponsorship by the U.S. Department of Health and Human Services (HHS). The designation represents a key milestone in Tecsys’ progression toward FedRAMP Class C Certification (formerly Moderate). The Class C Certification covers systems handling sensitive data where unauthorized access, modification or loss would have serious consequences – a standard directly relevant in healthcare and mission-critical government operations. Through the HHS sponsorship, Tecsys is aligning its Elite platform with stringent federal security and compliance standards, enabling agencies to confidently deploy its advanced supply chain capabilities in highly regulated environments. Listing on the FedRAMP Marketplace as 'Agency Auth In Process' provides federal agencies with visibility into Tecsys’ progress toward certification and facilitates engagement with procurement and evaluation teams seeking compliant cloud solutions. With FedRAMP Class C Certification, Tecsys will further enable federal agencies to gain real-time visibility into critical medical and operational supply chains, strengthen resilience and continuity of operations, and meet stringent federal requirements for security, privacy, and compliance. Tecsys works with more than 1,000 customer sites worldwide across healthcare and distribution, including over 50 health systems such as Texas Children's Hospital, Intermountain Health and Sanford Health. Tecsys Elite, the company’s core platform, offers purpose-built capabilities with healthcare supply chain and warehouse management systems, pharmacy inventory management and hospital point-of-use visibility capabilities. Its Warehouse Management System was recently recognized by Gartner as a Challenger in the Magic Quadrant for the 15th consecutive year. Recent Insider Transactions • May 06
Chairman of the Board recently sold CA$86k worth of stock On the 1st of May, David Brereton sold around 2k shares on-market at roughly CA$35.88 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. David has been a net seller over the last 12 months, reducing personal holdings by CA$825k. Recent Insider Transactions • Apr 15
Chairman of the Board recently sold CA$72k worth of stock On the 10th of April, David Brereton sold around 2k shares on-market at roughly CA$30.00 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. David has been a net seller over the last 12 months, reducing personal holdings by CA$767k. Recent Insider Transactions • Mar 29
Independent Director recently bought CA$94k worth of stock On the 24th of March, Stephany Verstraete bought around 3k shares on-market at roughly CA$27.31 per share. This trade did not impact their existing holding. This was the largest purchase by an insider in the last 3 months. Despite this recent purchase, insiders have collectively sold CA$5.1m more in shares than they bought in the last 12 months. Buy Or Sell Opportunity • Mar 16
Now 22% overvalued Over the last 90 days, the stock has fallen 15% to CA$27.15. The fair value is estimated to be CA$22.20, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 7.3% over the last 3 years. Earnings per share has grown by 27%. Declared Dividend • Mar 08
Third quarter dividend of CA$0.09 announced Shareholders will receive a dividend of CA$0.09. Ex-date: 25th March 2026 Payment date: 15th April 2026 Dividend yield will be 1.2%, which is higher than the industry average of 0.2%. Sustainability & Growth Dividend is covered by both earnings (83% earnings payout ratio) and cash flows (33% cash payout ratio). The dividend has increased by an average of 14% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 123% over the next 2 years, which should provide support to the dividend and adequate earnings cover. Reported Earnings • Mar 05
Third quarter 2026 earnings: EPS exceeds analyst expectations Third quarter 2026 results: EPS: CA$0.12 (up from CA$0.081 in 3Q 2025). Revenue: CA$48.5m (up 7.3% from 3Q 2025). Net income: CA$1.73m (up 45% from 3Q 2025). Profit margin: 3.6% (up from 2.6% in 3Q 2025). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 38%. Revenue is forecast to grow 10% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Software industry in Canada. Over the last 3 years on average, earnings per share has increased by 27% per year but the company’s share price has remained flat, which means it is significantly lagging earnings. Ankündigung • Feb 18
Tecsys Inc. to Report Q3, 2026 Results on Mar 04, 2026 Tecsys Inc. announced that they will report Q3, 2026 results After-Market on Mar 04, 2026 Price Target Changed • Feb 12
Price target decreased by 12% to CA$39.08 Down from CA$44.60, the current price target is an average from 6 analysts. New target price is 68% above last closing price of CA$23.22. Stock is down 50% over the past year. The company is forecast to post earnings per share of CA$0.40 for next year compared to CA$0.30 last year. Price Target Changed • Dec 18
Price target decreased by 8.0% to CA$44.60 Down from CA$48.50, the current price target is an average from 5 analysts. New target price is 39% above last closing price of CA$32.10. Stock is down 29% over the past year. The company is forecast to post earnings per share of CA$0.39 for next year compared to CA$0.30 last year. Recent Insider Transactions • Dec 18
Executive Chairman recently sold CA$79k worth of stock On the 12th of December, David Brereton sold around 2k shares on-market at roughly CA$32.72 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. David has been a net seller over the last 12 months, reducing personal holdings by CA$2.5m. Declared Dividend • Dec 07
Second quarter dividend increased to CA$0.09 Dividend of CA$0.09 is 5.9% higher than last year. Ex-date: 17th December 2025 Payment date: 6th January 2026 Dividend yield will be 1.0%, which is higher than the industry average of 0.2%. Sustainability & Growth Dividend is not adequately covered by earnings (93% earnings payout ratio). However, it is well covered by cash flows (47% cash payout ratio). The dividend has increased by an average of 14% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. The company's earnings per share (EPS) would need to grow by 2.9% to bring the payout ratio under control. EPS is expected to grow by 51% over the next year, which is sufficient to bring the dividend into a sustainable range. Reported Earnings • Dec 05
Second quarter 2026 earnings: EPS and revenues exceed analyst expectations Second quarter 2026 results: EPS: CA$0.12 (up from CA$0.051 in 2Q 2025). Revenue: CA$48.6m (up 15% from 2Q 2025). Net income: CA$1.77m (up 133% from 2Q 2025). Profit margin: 3.6% (up from 1.8% in 2Q 2025). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 2.9%. Earnings per share (EPS) also surpassed analyst estimates by 80%. Revenue is forecast to grow 7.4% p.a. on average during the next 3 years, compared to a 17% growth forecast for the Software industry in Canada. Over the last 3 years on average, earnings per share has increased by 11% per year whereas the company’s share price has increased by 7% per year. Recent Insider Transactions • Dec 03
Executive Chairman recently sold CA$50k worth of stock On the 28th of November, David Brereton sold around 1k shares on-market at roughly CA$35.95 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. David has been a net seller over the last 12 months, reducing personal holdings by CA$2.5m. Ankündigung • Nov 21
Tecsys Inc. to Report Q2, 2026 Results on Dec 03, 2025 Tecsys Inc. announced that they will report Q2, 2026 results After-Market on Dec 03, 2025 Ankündigung • Nov 13
Tecsys Inc. Expands Access to Its Elite™? Supply Chain Platform Through AWS Marketplace Tecsys Inc. announced that its Elite™? platform is now available in AWS Marketplace, giving healthcare and complex distribution organizations faster, more direct access to its enterprise-grade technology. The availability of Elite™? in AWS Marketplace reflects a commitment to make enterprise supply chain solutions more accessible. Through AWS Marketplace, organizations can easily procure, deploy and manage Tecsys' cloud-based technology while benefiting from the security, scalability and simplified billing of AWS. With Tecsys' Elite™? platform, healthcare systems and complex distributors gain visibility and control across their supply chains, to improve inventory utilization, optimize fulfillment performance and enhance service quality. Built to adapt to the nuances of each customer's operation, the platform empowers organizations to configure workflows, data views and automations that reflect their unique processes. Declared Dividend • Sep 08
First quarter dividend of CA$0.085 announced Shareholders will receive a dividend of CA$0.085. Ex-date: 19th September 2025 Payment date: 3rd October 2025 Dividend yield will be 1.0%, which is higher than the industry average of 0.2%. Sustainability & Growth Dividend is not covered by earnings (111% earnings payout ratio). However, it is well covered by cash flows (42% cash payout ratio). The dividend has increased by an average of 14% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. The company's earnings per share (EPS) would need to grow by 23% to bring the payout ratio under control. EPS is expected to grow by 55% over the next year, which is sufficient to bring the dividend into a sustainable range. Reported Earnings • Sep 05
First quarter 2026 earnings: EPS in line with expectations, revenues disappoint First quarter 2026 results: EPS: CA$0.05 (down from CA$0.054 in 1Q 2025). Revenue: CA$46.0m (up 8.7% from 1Q 2025). Net income: CA$762.0k (down 4.5% from 1Q 2025). Profit margin: 1.7% (down from 1.9% in 1Q 2025). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 10% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Software industry in Canada. Over the last 3 years on average, earnings per share has fallen by 4% per year whereas the company’s share price has remained flat. Ankündigung • Aug 26
Tecsys Inc. to Report Q1, 2026 Results on Sep 04, 2025 Tecsys Inc. announced that they will report Q1, 2026 results After-Market on Sep 04, 2025 Recent Insider Transactions Derivative • Jul 02
Independent Director exercised options to buy CA$102k worth of stock. On the 30th of June, David Booth exercised options to buy 3k shares at a strike price of around CA$30.78, costing a total of CA$81k. This transaction amounted to 5.8% of their direct individual holding at the time of the trade. Since March 2025, David has owned 45.74k shares directly. Company insiders have collectively sold CA$1.9m more than they bought, via options and on-market transactions in the last 12 months. Buy Or Sell Opportunity • Jun 30
Now 21% undervalued after recent price drop Over the last 90 days, the stock has fallen 9.5% to CA$36.40. The fair value is estimated to be CA$45.91, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 9.1% over the last 3 years. Earnings per share has declined by 17%. Reported Earnings • Jun 27
Full year 2025 earnings: EPS misses analyst expectations Full year 2025 results: EPS: CA$0.30 (up from CA$0.13 in FY 2024). Revenue: CA$176.5m (up 3.0% from FY 2024). Net income: CA$4.46m (up 141% from FY 2024). Profit margin: 2.5% (up from 1.1% in FY 2024). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 9.1%. Revenue is forecast to grow 10% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Software industry in Canada. Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings. Ankündigung • Jun 25
Tecsys Inc., Annual General Meeting, Sep 04, 2025 Tecsys Inc., Annual General Meeting, Sep 04, 2025. Ankündigung • Jun 14
Tecsys Inc. to Report Q4, 2025 Results on Jun 26, 2025 Tecsys Inc. announced that they will report Q4, 2025 results After-Market on Jun 26, 2025 Buy Or Sell Opportunity • Apr 08
Now 20% overvalued Over the last 90 days, the stock has fallen 15% to CA$37.26. The fair value is estimated to be CA$30.99, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 9.6% over the last 3 years. Earnings per share has declined by 28%. Recent Insider Transactions • Apr 02
CEO, President & Director recently sold CA$3.0m worth of stock On the 31st of March, Peter Brereton sold around 72k shares on-market at roughly CA$41.00 per share. This transaction amounted to 19% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was Peter's only on-market trade for the last 12 months. Recent Insider Transactions Derivative • Apr 01
CEO, President & Director exercised options to buy CA$2.9m worth of stock. On the 25th of March, Peter Brereton exercised options to buy 72k shares at a strike price of around CA$26.75, costing a total of CA$1.9m. This transaction amounted to 24% of their direct individual holding at the time of the trade. Since June 2024, Peter's direct individual holding has decreased from 395.89k shares to 300.73k. Company insiders have collectively bought CA$2.9m more than they sold, via options and on-market transactions, in the last 12 months. Recent Insider Transactions Derivative • Mar 19
Lead Independent Director exercised options to buy CA$214k worth of stock. On the 17th of March, Vernon Lobo exercised options to buy 5k shares at a strike price of around CA$26.75, costing a total of CA$135k. This transaction amounted to 7.5% of their direct individual holding at the time of the trade. Since June 2024, Vernon has owned 149.33k shares directly. Company insiders have collectively sold CA$3.4m more than they bought, via options and on-market transactions in the last 12 months. Recent Insider Transactions • Mar 16
Director recently bought CA$152k worth of stock On the 14th of March, Andrew Kirkwood bought around 4k shares on-market at roughly CA$39.71 per share. This trade did not impact their existing holding. This was the largest purchase by an insider in the last 3 months. Despite this recent purchase, insiders have collectively sold CA$981k more in shares than they bought in the last 12 months. Declared Dividend • Mar 10
Third quarter dividend of CA$0.085 announced Shareholders will receive a dividend of CA$0.085. Ex-date: 26th March 2025 Payment date: 16th April 2025 Dividend yield will be 0.8%, which is higher than the industry average of 0.2%. Payout Ratios Payout ratio: 39%. Cash payout ratio: 44%. Ankündigung • Mar 08
Tecsys Inc. announces Quarterly dividend, payable on April 16, 2025 Tecsys Inc. announced Quarterly dividend of CAD 0.0850 per share payable on April 16, 2025, ex-date on March 26, 2025 and record date on March 26, 2025. New Risk • Mar 06
New major risk - Revenue and earnings growth Earnings have declined by 13% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 13% per year over the past 5 years. Minor Risks Large one-off items impacting financial results. Significant insider selling over the past 3 months (CA$258k sold). Ankündigung • Feb 20
Tecsys Inc. to Report Q3, 2025 Results on Mar 05, 2025 Tecsys Inc. announced that they will report Q3, 2025 results After-Market on Mar 05, 2025 Recent Insider Transactions Derivative • Jan 12
Independent Director exercised options to buy CA$339k worth of stock. On the 9th of January, David Booth exercised options to buy 8k shares at a strike price of around CA$31.06, costing a total of CA$240k. This transaction amounted to 20% of their direct individual holding at the time of the trade. Since June 2024, David has owned 27.43k shares directly. Company insiders have collectively sold CA$3.9m more than they bought, via options and on-market transactions in the last 12 months. Recent Insider Transactions • Jan 07
Executive Chairman recently sold CA$108k worth of stock On the 3rd of January, David Brereton sold around 2k shares on-market at roughly CA$44.84 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. David has been a net seller over the last 12 months, reducing personal holdings by CA$1.0m. Recent Insider Transactions • Dec 10
Executive Chairman recently sold CA$66k worth of stock On the 6th of December, David Brereton sold around 2k shares on-market at roughly CA$43.96 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger sale worth CA$800k. David has been a net seller over the last 12 months, reducing personal holdings by CA$866k. Declared Dividend • Dec 08
Second quarter dividend increased to CA$0.085 Dividend of CA$0.085 is 6.3% higher than last year. Ex-date: 18th December 2024 Payment date: 3rd January 2025 Dividend yield will be 0.8%, which is higher than the industry average of 0.2%. Payout Ratios Payout ratio: 184%. Cash payout ratio: 74%. Reported Earnings • Dec 05
Second quarter 2025 earnings: EPS and revenues miss analyst expectations Second quarter 2025 results: EPS: CA$0.05 (up from CA$0.023 loss in 2Q 2024). Revenue: CA$42.4m (up 2.3% from 2Q 2024). Net income: CA$758.0k (up CA$1.10m from 2Q 2024). Profit margin: 1.8% (up from net loss in 2Q 2024). Revenue missed analyst estimates by 6.0%. Earnings per share (EPS) also missed analyst estimates by 48%. Revenue is forecast to grow 12% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Software industry in Canada. Over the last 3 years on average, earnings per share has fallen by 33% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings. Ankündigung • Nov 20
Tecsys Inc. to Report Q2, 2025 Results on Dec 04, 2024 Tecsys Inc. announced that they will report Q2, 2025 results After-Market on Dec 04, 2024 Recent Insider Transactions • Sep 15
Executive Chairman recently sold CA$800k worth of stock On the 12th of September, David Brereton sold around 20k shares on-market at roughly CA$40.00 per share. This transaction amounted to 2.2% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. David has been a net seller over the last 12 months, reducing personal holdings by CA$4.9m. Declared Dividend • Sep 11
First quarter dividend of CA$0.08 announced Shareholders will receive a dividend of CA$0.08. Ex-date: 20th September 2024 Payment date: 4th October 2024 Dividend yield will be 0.8%, which is higher than the industry average of 0.2%. Payout Ratios Payout ratio: 315%. Cash payout ratio: 97%. Ankündigung • Sep 10
Tecsys Inc. Announces Appointment to Its Board of Directors Tecsys Inc. announced the appointment of Stephany Verstraete and Sripriya Thinagar to its Board of Directors, effective September 5, 2024. This strategic move reflects Tecsys' commitment to strengthening its leadership team and enhancing its governance as the company continues to drive innovation in the supply chain sector. Verstraete is a distinguished technology and digital healthcare executive with over two decades of experience scaling businesses and leading transformative change in highly competitive environments. Her career includes significant roles at Teladoc Health, Expedia and PepsiCo, where she has driven remarkable results across multinational teams. She has a strong background in mergers and acquisitions, brand building and cross-channel marketing. Her passion for leveraging data and advanced technologies to deliver innovative experiences and create behavioral change has been a key factor in her success . Thinagar brings over 25 years of experience in technology and operational excellence, having held senior executive roles at Olo, Manhattan Associates and Bank of America. She has a background in leading global teams across product, platform and data engineering, with experience managing complex products across diverse sectors. Her insights into the competitive landscape of supply chain management, together with her deep understanding of a SaaS technology infrastructure, will help Tecsys continue to navigate an evolving industry and enhance its operational capabilities. Reported Earnings • Sep 06
First quarter 2025 earnings: EPS and revenues miss analyst expectations First quarter 2025 results: EPS: CA$0.05 (down from CA$0.08 in 1Q 2024). Revenue: CA$42.3m (flat on 1Q 2024). Net income: CA$798.0k (down 32% from 1Q 2024). Profit margin: 1.9% (down from 2.8% in 1Q 2024). Revenue missed analyst estimates by 5.8%. Earnings per share (EPS) also missed analyst estimates by 38%. Revenue is forecast to grow 10% p.a. on average during the next 2 years, compared to a 17% growth forecast for the Software industry in Canada. Over the last 3 years on average, earnings per share has fallen by 40% per year but the company’s share price has only fallen by 11% per year, which means it has not declined as severely as earnings. Ankündigung • Aug 24
Tecsys Inc. to Report Q1, 2025 Results on Sep 05, 2024 Tecsys Inc. announced that they will report Q1, 2025 results After-Market on Sep 05, 2024 Buy Or Sell Opportunity • Aug 04
Now 20% undervalued Over the last 90 days, the stock has risen 8.3% to CA$40.00. The fair value is estimated to be CA$50.05, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 11% over the last 3 years. Earnings per share has declined by 40%. Reported Earnings • Jul 29
Full year 2024 earnings: EPS misses analyst expectations Full year 2024 results: EPS: CA$0.13 (down from CA$0.14 in FY 2023). Revenue: CA$171.2m (up 12% from FY 2023). Net income: CA$1.85m (down 12% from FY 2023). Profit margin: 1.1% (down from 1.4% in FY 2023). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 25%. Revenue is forecast to grow 9.3% p.a. on average during the next 2 years, compared to a 17% growth forecast for the Software industry in Canada. Over the last 3 years on average, earnings per share has fallen by 40% per year but the company’s share price has only fallen by 8% per year, which means it has not declined as severely as earnings. Ankündigung • Jul 16
Tecsys Inc. Appoints Rex Ahlstrom as Chief Strategy Officer Tecsys Inc. announced the appointment of Rex Ahlstrom as Chief Strategy Officer (CSO), effective today. Ahlstrom brings over 25 years of experience in harnessing the power of data to create business value. His background in operational leadership, data strategy and technology product management will support Tecsys as it continues to innovate and grow.Before joining Tecsys, Ahlstrom served as CTO and EVP of Innovation and Growth at Syniti where he led the global Product and Engineering organization, successfully transitioningthe company from a perpetual software business model to a SaaS product and ARR model. Prior to Syniti, Ahlstrom founded and led SOALogix, which was acquired by SAP, and built MSI Software from the ground up, achieving significant market penetration. Ahlstrom's credentials include notable roles at SAP, TeleSciences CO Systems, Defense Systems Incorporated, Westinghouse Electric Corporation and SGS Thomson, where he led numerous high-impact projects and initiatives. He is recognized as an industry expert, an IBM Champion, and a member of the MindShare Alumni Network. Ahlstrom will collaborate across the enterprise to lead global initiatives and strategic business activities that maximize the value of Tecsys' evolving SaaS offering and growing data capabilities. Ahlstrom holds a Master of Science in Electrical Engineering from The Johns Hopkins University and a Bachelor of Science in Electrical Engineering from Drexel University. Declared Dividend • Jul 01
Fourth quarter dividend of CA$0.08 announced Shareholders will receive a dividend of CA$0.08. Ex-date: 12th July 2024 Payment date: 2nd August 2024 Dividend yield will be 0.9%, which is higher than the industry average of 0.2%. Sustainability & Growth Dividend is not covered by earnings (219% earnings payout ratio) nor is it covered by cash flows (111% cash payout ratio). The dividend has increased by an average of 16% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. The company's earnings per share (EPS) would need to grow by 144% to bring the payout ratio under control. EPS is expected to grow by 183% over the next 2 years, which is sufficient to bring the dividend into a sustainable range. Reported Earnings • Jun 28
Full year 2024 earnings: EPS misses analyst expectations Full year 2024 results: EPS: CA$0.13 (down from CA$0.14 in FY 2023). Revenue: CA$171.2m (up 12% from FY 2023). Net income: CA$1.85m (down 12% from FY 2023). Profit margin: 1.1% (down from 1.4% in FY 2023). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 25%. Revenue is forecast to grow 9.9% p.a. on average during the next 2 years, compared to a 17% growth forecast for the Software industry in Canada. Over the last 3 years on average, earnings per share has fallen by 40% per year but the company’s share price has only fallen by 6% per year, which means it has not declined as severely as earnings. Ankündigung • Jun 26
Tecsys Inc., Annual General Meeting, Sep 05, 2024 Tecsys Inc., Annual General Meeting, Sep 05, 2024. Ankündigung • Jun 19
Tecsys Inc. to Report Q4, 2024 Results on Jun 27, 2024 Tecsys Inc. announced that they will report Q4, 2024 results After-Market on Jun 27, 2024 Recent Insider Transactions Derivative • Apr 16
Lead Independent Director exercised options to buy CA$430k worth of stock. On the 12th of April, Vernon Lobo exercised options to buy 11k shares at a strike price of around CA$14.29, costing a total of CA$162k. This transaction amounted to 20% of their direct individual holding at the time of the trade. Since June 2023, Vernon's direct individual holding has increased from 49.00k shares to 56.00k. Company insiders have collectively sold CA$7.1m more than they bought, via options and on-market transactions in the last 12 months. New Risk • Apr 04
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 2.3% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Minor Risks Profit margins are more than 30% lower than last year (1.2% net profit margin). Shareholders have been diluted in the past year (2.3% increase in shares outstanding). Recent Insider Transactions Derivative • Mar 29
CEO, President & Director exercised options and sold CA$2.3m worth of stock On the 26th of March, Peter Brereton exercised 130.81k options to receive shares at no cost, then sold 100k of them for an average price of CA$37.50 per share and kept the remainder. For the year to April 2017, Peter's total compensation was 36% salary and 64% other compensation. This indicates that these sales could comprise a meaningful part of their income for the year. Since June 2023, Peter's direct individual holding has decreased from 299.92k shares to 284.92k. Company insiders have collectively sold CA$7.4m more than they bought, via options and on-market transactions in the last 12 months. Upcoming Dividend • Mar 13
Upcoming dividend of CA$0.08 per share Eligible shareholders must have bought the stock before 20 March 2024. Payment date: 11 April 2024. The company is paying out more than 100% of its profits but is generating plenty of cash to support the dividend. Trailing yield: 0.9%. Lower than top quartile of Canadian dividend payers (6.4%). Higher than average of industry peers (0.2%). Declared Dividend • Mar 04
Third quarter dividend of CA$0.08 announced Shareholders will receive a dividend of CA$0.08. Ex-date: 20th March 2024 Payment date: 11th April 2024 Dividend yield will be 0.8%, which is higher than the industry average of 0.2%. Payout Ratios Payout ratio: 53%. Cash payout ratio: 50%. Reported Earnings • Mar 01
Third quarter 2024 earnings released: EPS: CA$0.05 (vs CA$0.061 in 3Q 2023) Third quarter 2024 results: EPS: CA$0.05 (down from CA$0.061 in 3Q 2023). Revenue: CA$43.8m (up 13% from 3Q 2023). Net income: CA$759.0k (down 14% from 3Q 2023). Profit margin: 1.7% (down from 2.3% in 3Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 17% growth forecast for the Software industry in Canada. Over the last 3 years on average, earnings per share has fallen by 35% per year but the company’s share price has only fallen by 8% per year, which means it has not declined as severely as earnings. Ankündigung • Mar 01
Tecsys Inc. Revises Financial Guidance for Fiscal Year 2024 Tecsys Inc. is revising financial guidance for fiscal year 2024. For the period, company expects Total Revenue Growth to be 11%-14% compared to Previous Guidance was 10%-15%. Ankündigung • Feb 16
Tecsys Inc. to Report Q3, 2024 Results on Feb 29, 2024 Tecsys Inc. announced that they will report Q3, 2024 results After-Market on Feb 29, 2024 Recent Insider Transactions • Dec 09
Executive Chairman recently sold CA$2.8m worth of stock On the 5th of December, David Brereton sold around 90k shares on-market at roughly CA$31.07 per share. This transaction amounted to 8.9% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. David has been a net seller over the last 12 months, reducing personal holdings by CA$9.0m. Reported Earnings • Dec 02
Second quarter 2024 earnings: EPS and revenues miss analyst expectations Second quarter 2024 results: CA$0.02 loss per share (down from CA$0.049 profit in 2Q 2023). Revenue: CA$41.5m (up 8.9% from 2Q 2023). Net loss: CA$340.0k (down 148% from profit in 2Q 2023). Revenue missed analyst estimates by 2.0%. Earnings per share (EPS) were also behind analyst expectations. Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Software industry in Canada. Over the last 3 years on average, earnings per share has fallen by 28% per year but the company’s share price has only fallen by 7% per year, which means it has not declined as severely as earnings. Ankündigung • Nov 29
Tecsys Inc. Announces Elite WMS for Healthcare Distribution Tecsys Inc. announced Elite WMS for Healthcare Distribution, a warehouse management system with embedded serialized DSCSA support designed for efficient and continuous compliance with DSCSA regulations as outlined by the U.S. Food and Drug Administration (FDA). Tecsys' Elite WMS for Healthcare Distribution is the industry's first warehouse management system that locally maintains full inference data on the GS1 system of standards, specifically the Serial Global Trade Item Number (SGTIN) and the Serial Shipping Container Code (SSCC). In addition to ensuring efficiency of critical warehouse functions, the system features real-time compliance and streamlined workflows for receiving, put away and fulfillment. Its unified approach eliminates the need for multiple systems to run simultaneously, avoiding dual-entry workflows. With the DSCSA mandate requiring electronic documentation of products and ownership now in effect, Elite WMS for healthcare Distribution provides wholesale pharmaceutical distributors and 3PLs a market-tested solution for regulatory adherence. Trading partner readiness extends downstream to health system and retail pharmacy clients, who must ensure upstream and downstream compliance to facilitate traceability through to the point of use. From its involvement with the Healthcare Distribution Alliance (HDA) to its participation in DSCSA serialization seminars, Tecsys continues to invest in its healthcare and pharmacy-specific supply chain traceability platform. Elite WMS for Healthcare Distribution leverages Tecsys' regulatory and compliance expertise in hospital logistics, providing the highest degree of functional maturity in the industry. This integrated DSCSA serialization compliance minimizes redundant integrations and manual record checks, enabling real-time inventory reconciliation.